drugset
drugset / Trial / NCT05547399

Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults

NCT05547399 ↗

Phase 1 Completed 43 enrolled BeiGene
RandomizedCrossoverOpen-labelBasic science

Summary

Study to assess the relative bioavailability of zanubrutinib tablets compared to capsules and to evaluate the effects of food on the pharmacokinetics (PK) of the zanubrutinib tablet.

Timeline

Start
2022-06-07
Primary completion
2022-12-07
Completion
2022-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Zanubrutinib Small molecule — Oral

Indications

No indication recorded.